SCHEMBL25422956

SCHEMBL25422956

COc1ccc2[nH]cc(C(=O)C(=O)N(C)C(C)C)c2c1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 4/20 0.47
▸ HTR7 P34969 2/20 0.39
▸ HTR6 P50406 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HIF1A Q16665 1/20 0.35
▸ CTNNB1 P35222 1/20 0.34
▸ WNT3A P56704 1/20 0.34
▸ GABRP O00591 2/20 0.34
▸ GABRD O14764 2/20 0.34
▸ GABRA1 P14867 2/20 0.34
▸ GABRB1 P18505 2/20 0.34
▸ GABRG2 P18507 2/20 0.34
▸ GABRB3 P28472 2/20 0.34
▸ GABRA5 P31644 2/20 0.34
▸ GABRA3 P34903 2/20 0.34
▸ GABRA2 P47869 2/20 0.34
▸ GABRB2 P47870 2/20 0.34
▸ GABRA4 P48169 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25748568 0.89 HTR1A (0.45) HTR1AHTR7HTR6CTNNB1WNT3A
SCHEMBL25747864 0.87 HTR1A (0.35) HTR1AALDH1A1LMNAMAPTHIF1A
SCHEMBL25423216 0.85 GPR84 (0.40) HTR1AHTR7HTR6ALDH1A1PRKAB2
SCHEMBL25423289 0.83 HTR1A (0.50) HTR1AHTR7HTR6ALDH1A1LMNA
SCHEMBL25748562 0.82 HTR1A (0.48) HTR1AHTR7HTR6ALDH1A1LMNA
SCHEMBL25424226 0.81 MAPK14 (0.36) HTR1AMAPK14PRKAB2PRKAG1PRKAA2
SCHEMBL25423742 0.81 HTR1A (0.48) HTR1AHTR7HTR6LMNAMAPT
SCHEMBL25423229 0.80 NR4A2 (0.33) ALDH1A1LMNAMAPT
SCHEMBL25436610 0.77 NR4A2 (0.36) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL31077729 0.74 MAPK14 (0.39) HTR1AALDH1A1LMNAMAPTHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250101038-A1 COMPOUNDS Psylo Pty Ltd (AU) 2025-03-27 — — US disclosed
EP-4452937-A1 COMPOUNDS Psylo Pty Ltd (AU) 2024-10-30 — — EP disclosed
CN-118715204-A Compounds of formula (I) 普赛洛私人有限公司 2024-09-27 — — CN disclosed
WO-2023115166-A1 COMPOUNDS Psylo Pty Ltd (AU) 2023-06-29 — — WO disclosed
WO-2023115166-A1 COMPOUNDS Psylo Pty Ltd (AU) 2023-06-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250101038-A1 COMPOUNDS NLN, SLC18A2, PYGB HTR1A 185/4885HTR7 192/4885HTR6 54/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback